Back to results
US 2016/0279236 A1Published application
Use of rapamycin as vaccine adjuvant and preparation method therefor
AssigneeInstitut Pasteur of Shanghai, Chinese Academy of Sciences
Inventorshui XIAO, Chuanping Yuan, Aiping ZANG, Min DU
Life of this patent
Estimating the term…
Abstract
Disclosed are an immuno-enhancer composition, a use of same as a vaccine adjuvant, and a preparation method therefor. The composition comprises rapamycin and a Toll-like receptor agonist-type adjuvant.
Claims19
An immune enhancer composition, wherein the composition comprises rapamycin or derivatives thereof, and a Toll-like receptor agonist adjuvant.
Use of rapamycin or a derivative thereof in the preparation of formulations in which the activity of Toll-like receptor agonist adjuvant is enhanced.
Dependencies are inferred from the claim text.